Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
56.07
+0.90 (1.63%)
At close: Nov 20, 2024, 4:00 PM
67.51
+11.44 (20.40%)
Pre-market: Nov 21, 2024, 7:31 AM EST
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $5.20 billion as of November 21, 2024. Its market cap has increased by 157.89% in one year.
Market Cap
5.20B
Enterprise Value
4.39B
1-Year Change
157.89%
Ranking
Category
Stock Price
$56.07
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $5.20B, an increase of 822.07%. That is a compound annual growth rate of 41.92%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Waystar Holding | 5.38B |
| Ionis Pharmaceuticals | 5.34B |
| Inspire Medical Systems | 5.30B |
| Krystal Biotech | 5.09B |
| Avidity Biosciences | 5.08B |
| PROCEPT BioRobotics | 5.03B |
| Stevanato Group | 5.00B |
| ADMA Biologics | 4.81B |